The European Medicines Agency (EMA) confirmed the link between Ozempic and NAION (non-arteritic anterior ischemic optic neuropathy) in early June 2025. This drug regulator went on to say a NAION warning would be added to the drug labels for the semaglutide-containing drugs Wegovy, Rybelsus, and … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Drug Injury Case Evaluation – Free. Confidential. No Obligation.
➤ Information About the Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Recent Side Effects Blog Articles
➤ Collection of Earlier Blog Articles
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent News & Case Reports
Ozempic Blindness Legal Cases Filed Against Novo Nordisk in April 2025
Patients who have filed Ozempic blindness legal cases had developed nonarteritic anterior ischemic optic neuropathy (NAION) while using Ozempic. These cases are product liability failure to warn lawsuits filed against the responsible drug company, Novo Nordisk, because the Ozempic drug label does … More
Vision Loss Linked to Ozempic and Rybelsus Use by Diabetes Patients
The relatively new drug safety issue of vision loss linked to Ozempic and Rybelsus was the subject of a recent medical study that had this stated Objective, or purpose: "To investigate the association between semaglutide use and the risk of NAION among patients with diabetes." On March 27, 2025, … More
Ozempic Eye Problems Caused by Semaglutide-Related NAION
Ozempic eye problems caused by semaglutide-related NAION are being investigated as possible drug injury lawsuits to be filed on behalf of patients against Novo Nordisk, the responsible drug company. Similar Wegovy eye problems and Rybelsus eye problems are also possible lawsuits against Novo Nordisk … More
The Depo-Provera Warning About Meningioma in Europe
The European Medicines Agency (EMA) recommended a Depo-Provera warning about meningioma in September 2024. One wonders why the FDA has not followed this EMA regulatory action. Therefore, the Depo-Provera drug label in the US still does not include a warning about meningioma. The following … More
Why Are There Depo-Provera Brain Tumor Warnings In Europe But Not US?
Depo-Provera drug injury lawsuits for women who have been diagnosed with a specific type of brain tumor, intracranial meningioma, are being filed against the responsible pharmaceutical companies. A primary focus of these legal cases will be why the Depo-Provera drug label in the US does not include … More